Dr. Kim Chi Named a Highly Cited Researcher in 2025

Dr. Kim Chi, medical oncologist and clinician-scientist with BC Cancer, has been named a highly cited researcher in 2025 by Clarivate, a global organization that analyzes academic publications, citations and research impact.

“This recognition reflects my career-long commitment to improving care for people with prostate cancer,” says Dr. Kim Chi, medical oncologist, BC Cancer. “Our research has always been driven by the needs of patients, and this honour highlights the collective efforts of our collaborators, co-investigators and dedicated staff who make this work possible.”

Dr. Christian Steidl receives AstraZeneca and Leukemia & Lymphoma Society Grant

Dr. Christian Steidl, senior scientist and Executive Director, Research at BC Cancer, is the recipient of a 2025 Operating Grant in Blood Cancer, co-funded by AstraZeneca Canada and the Leukemia & Lymphoma Society of Canada.

The research is dedicated to developing innovative tools for precise and efficient gene editing in B-cell lymphomas. By targeting the underlying genetic causes of cancer, this work paves the way for novel treatment strategies and opens new possibilities for patients living with B-cell lymphoma.

Back to top